Publications by authors named "Ana Cavey"

Claim this Profile
E
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Ruth Dobson, Matthew Craner, Ed Waddingham, Aleisha Miller, Jayant Pindoria, Ana Cavey

Mult Scler Relat Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
Silvia Messina, Romina Mariano, Adriana Roca-Fernandez, Ana Cavey, Maciej Jurynczyk

Mult Scler· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis.
Ruth Dobson, Matthew Craner, Ed Waddingham, Aleisha Miller, Ana Cavey

BMJ Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
George Tackley, Yazhuo Kong, Rachel Minne, Silvia Messina, Anderson Winkler, Ana Cavey

Neuroimage· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
Silvia Messina, Romina Mariano, Ruth Geraldes, Su-Hyun Kim, Chanjira Satukijcha, Ana Cavey

Mult Scler Relat Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling.
Tianrong Yeo, Fay Probert, Maciej Jurynczyk, Megan Sealey, Ana Cavey

Neurol Neuroimmunol Neuroinflamm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
Shelly Coe, Jo Cossington, Johnny Collett, Andrew Soundy, Hooshang Izadi, Ana Cavey

J Neurol Neurosurg Psychiatry· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Maciej Jurynczyk, Fay Probert, Tianrong Yeo, George Tackley, Tim D W Claridge, Ana Cavey

Acta Neuropathol Commun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Pedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, Ana Cavey, Cris S Constantinescu

JAMA Neurol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Alex M Dickens, James R Larkin, Julian L Griffin, Ana Cavey, Lucy Matthews

Neurology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Tarunya Arun, Valentina Tomassini, Emilia Sbardella, Michiel B de Ruiter, Lucy Matthews, Ana Cavey

Brain· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydration and independence in activities of daily living in people with multiple sclerosis: a pilot investigation.
Johnny Collett, Helen Dawes, Ana Cavey, Andy Meaney, Catherine Sackley

Disabil Rehabil· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Charlotte J Stagg, Bethan Lang, Jonathan G Best, Karen McKnight, Ana Cavey

Epilepsia· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis